Evidence map›Paper›PMID 18040841›Full record

ReviewJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology2007

Battle of animal models.

Yuri Persidsky, Howard Fox

Abstract readComparative StudyReview
In one paragraph

Review in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yuri PersidskyDepartment of Pharmacology/Experimental Neuroscience, University of Nebraska Medical Center, 985215 Nebraska Medical Center, Omaha, NE 68198-5215, USA. ypersids@unmc.edu
Howard Fox

Funding

Therapeutics Core (Page 286)P30MH062261 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI GENDELMAN, HOWARD E · 2000 to 2021
$37.7M
VIRAL SHUTOFF OF HOST TRANSCRIPTION--PBCV-1 INFECTEDP20RR015635 · NCRR · UNIVERSITY OF NEBRASKA LINCOLN · PI WOOD, CHARLES · 2000 to 2009
$22.1M
Proteomics CoreP01NS043985 · NINDS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI ZHENG, JIALIN CHARLES · 2003 to 2012
$11.8M
Project 4P01DA012444 · NIDA · SCRIPPS RESEARCH INSTITUTE · PI HENRIKSEN, STEVEN · 2000 to 2004
$8.9M
Toward a Mouse Model of HIV-1 Infection and Drug AddictionR01DA017618 · NIDA · ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS · PI POTASH, MARY JANE, VOLSKY, DAVID J · 2004 to 2015
$6.2M
BBB Tight Junctions During HIV-1 dementiaR01MH065151 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI PERSIDSKY, YURI · 2002 to 2016
$5.9M
CNS injury caused by HIV-1 and alcohol: Protective effects of CB2 activationR37AA015913 · NIAAA · TEMPLE UNIV OF THE COMMONWEALTH · PI PERSIDSKY, YURI · 2010 to 2019
$3.6M
Efffects of opiate virus/host response in SHIV/macaqueR01DA015013 · NIDA · UNIVERSITY OF MISSOURI KANSAS CITY · PI KUMAR, ANIL · 2001 to 2011
$3.1M
MORPHINE ACTIONS ON THE IMMUNE SYSTEMR01DA007058 · NIDA · SETON HALL UNIVERSITY · PI CHANG, SULIE L. · 1992 to 2011
$2.8M
Alcohol and AIDS: Pathogenesis and Immunity in MacaqueR01AA015045 · NIAAA · UNIVERSITY OF MISSOURI KANSAS CITY · PI KUMAR, ANIL · 2004 to 2008
$1.9M
PPAR-gamma-mediated neuroprotection against HIV-1 and alcohol CNS injuryR01AA015913 · NIAAA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI PERSIDSKY, YURI · 2005 to 2009
$1.6M
Morphine Actions on the Immune SystemK02DA016149 · NIDA · SETON HALL UNIVERSITY · PI CHANG, SULIE L. · 2003 to 2012
$1.1M
NCRR NIH HHS P20 RR015635NCRR NIH HHS RR15635NIAAA NIH HHS AA015045NIAAA NIH HHS AA015913NIAAA NIH HHS R01 AA015045NIAAA NIH HHS R01 AA015913NIAAA NIH HHS R37 AA015913NIDA NIH HHS DA007058NIDA NIH HHS DA015013NIDA NIH HHS DA016149NIDA NIH HHS DA019836NIDA NIH HHS DA020416NIDA NIH HHS DA12444NIDA NIH HHS DA12824NIDA NIH HHS DA17618NIDA NIH HHS K02 DA016149NIDA NIH HHS P01 DA012444NIDA NIH HHS R01 DA007058NIDA NIH HHS R01 DA015013NIDA NIH HHS R01 DA017618NIDA NIH HHS R21 DA019836NIDA NIH HHS R56 DA020416NIMH NIH HHS MH062261NIMH NIH HHS MH47680NIMH NIH HHS MH65151NIMH NIH HHS P30 MH062261NIMH NIH HHS R01 MH065151NINDS NIH HHS NS043985NINDS NIH HHS NS54580NINDS NIH HHS P01 NS043985NINDS NIH HHS R21 NS054580
6 · The paper itself

Abstract

This is a brief summary of the animal models session held during the 12th Annual Meeting of the Society on NeuroImmune Pharmacology, Santa Fe, NM, USA. This session provided important information for participants on availability and utility of animal models for the studies of HIV-1 central nervous system infection and drug abuse. It highlighted animal model relevance to human disease/condition, its utility for the studies of pathogenesis, potential importance for the development of therapeutics, and demonstrated limitations/pitfalls.

Indexed as

Disease Models, AnimalModels, AnimalAnimalsCentral Nervous System InfectionsCongresses as TopicHIV InfectionsHumans

Identifiers

PMID18040841
PMCPMC2405906

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.